Health Tech by the Numbers: Growth, AI Clearances, and the Hybrid Care Shift
Fresh data shows digital health growing into a multi-hundred-billion-dollar market as AI tools gain regulatory traction and telehealth settles into a durable share of care. Here’s what the latest statistics mean for strategists across virtual care, EHRs, and connected devices.
Health Tech by the Numbers
The digital health market continues to expand, with the sector projected to surpass $800 billion by 2030 on high-teens compound annual growth, according to industry sizing from Grand View Research. After a reset in 2022–2023, deal activity is showing signs of stabilization as strategic buyers and late-stage backers focus on scalable care models and enterprise integrations.
Funding patterns have shifted from growth-at-all-costs to metrics-first discipline. Analysts report that investment has concentrated in virtual care, AI-enabled diagnostics, and data interoperability platforms, with a rebound in late-stage rounds for category leaders, CB Insights’ State of Digital Health shows. That recalibration is reshaping roadmaps for incumbents like Teladoc Health while drawing in retail and payer platform entrants.
Telehealth Becomes the New Front Door
Telehealth has cemented a durable role in the care continuum, stabilizing at roughly the mid-teens share of outpatient visits in the U.S.—well above pre‑pandemic baselines—McKinsey analysis indicates. Scale players including Teladoc Health have broadened capabilities from on-demand urgent care to chronic care and mental health, while retail-backed offerings such as Amazon Clinic and integrated care platforms from CVS Health have optimized convenience and price transparency.
Payer-backed virtual care models are also maturing, with Optum folding telehealth into digital navigation, behavioral health, and pharmacy benefits. The strategic focus is shifting to hybrid care—blending virtual and in‑person visits—where analytics determines the “right site of care” and steers patients to the most efficient channel.
AI Diagnostics, EHR Interoperability, and the Data Dividend
AI and machine learning are moving from pilots to production in clinical workflows. The U.S. Food and Drug Administration lists more than 500 authorized AI/ML‑enabled medical devices across imaging, cardiology, and monitoring categories, underscoring accelerating commercialization on its public tally. Imaging leaders including Siemens Healthineers and Philips...